Wenju Ren

Dr. Wenju Ren


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2022 in Journal of Materials Science
Verified
Journal Article
Closed access
PDF file
WRWenju Ren
Wenju Ren
TZTaixiong Zheng
Taixiong Zheng
CPChanghao Piao
Changhao Piao
DBDaryn Eugene Benson
Daryn Eugene Benson
XWXin Wang
Xin Wang
SLShen Lu
Shen Lu

1 November 2021 in Journal of Energy Chemistry
Verified
Journal Article
Closed access
QHQingshui Hong
Qingshui Hong
TLTangyi Li
Tangyi Li
SZShisheng Zheng
Shisheng Zheng
HCHaibiao Chen
Haibiao Chen
WRWenju Ren
Wenju Ren
FPFeng Pan
Feng Pan

8 December 2025 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
WRWenju Ren
Wenju Ren
Rui TanRui Tan
Rui Tan
CQChenyang Qi
Chenyang Qi
YYYuhang Yang
Yuhang Yang
XWXin Wang
Xin Wang
TZTaixiong Zheng
Taixiong Zheng

1 January 2026 in Transboundary and Emerging Diseases
Verified
Journal Article
Open access
WRWenju Ren
Wenju Ren
RYRui Yang
Rui Yang
CQChenyang Qi
Chenyang Qi
JZJie Zhou
Jie Zhou
LYLiu Yang
Liu Yang
LFLi zhi Fu
Li zhi Fu
The lack of simple, rapid, accurate, and low‐cost on‐site diagnostic technology has seriously hindered the effective prevention and control of major infectious diseases such as African swine fever (ASF). This study presents an integrated, portable diagnostic system comprising a low‐cost microfluidic chip and a fully automatic, portable device for simultaneously detecting nine samples. The aim is to achieve rapid on‐site detection of African swine fever virus (ASFV) nucleic acid. The system integrates magnetic bead nucleic acid extraction, transfer, loop‐mediated isothermal amplification (LAMP), and optical detection functions, and can perform fully automatic, closed‐tube analysis of 9 samples in 25 min, effectively avoiding aerosol pollution. The detection limit for the ASFV P10 gene is 10 2 copies/μL. In a blind test involving 87 clinical samples, the system demonstrated excellent performance with a clinical sensitivity and specificity of 97.6% (42/44) and 98.0% (42/43), respectively, and an accuracy of 96.6% (84/87). When the sample concentration exceeds the detection limit, sensitivity can reach 100 %. The core advantages of this method are that it is fast, accurate, and low cost, and does not require professional laboratories or operators. Its modular design makes it easy to expand to a 100‐channel, high‐throughput detection system at low cost. This system provides a powerful technical tool for large‐scale epidemic screening and prevention in areas with limited resources, offering significant public health and economic value.